RESPIRATORY SYNCYTIAL VIRUS ON ALLERGIC AIRWAY DISEASE
RESPIRATORY SYNCYTIAL VIRUS ON ALLERGIC AIRWAY DISEASE
批准号:
2878887
负责人:
BARNEY S GRAHAM
金额:
$30.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 2004-02-29
中文摘要
呼吸道合胞病毒(RSV)是引起
儿童时期患有严重的下呼吸道疾病。严重呼吸道合胞病毒感染
疾病与儿童哮喘有关,哮喘的发病率
在工业化国家,这一比例正在增加。因此,理解
呼吸道合胞病毒和变应原诱导的呼吸道的分子和细胞相关性
功能障碍对于设计预防性疫苗和
影响儿童发病机制的免疫治疗策略
哮喘。这项提案的目标是定义病毒学和
急性呼吸道高反应性(AHR)的免疫学决定因素
呼吸道合胞病毒感染在变应原致敏的背景下。特别是,
呼吸道合胞病毒G糖蛋白诱导的呼吸道功能障碍的机制
已定义。此外,选定的细胞因子和T细胞亚群的作用
卵蛋白致敏、呼吸道合胞病毒感染小鼠AHR的诱导
将会被定义。在正常情况下,RSV感染会诱导Th1-
类似于细胞因子的表达模式。我们的初步数据支持
卵子致敏产生免疫环境的假说
这促进了RSV特异性的CD4+Th2对感染的反应,从而进一步
增强卵子特异性过敏性呼吸道炎症和AHR。此外,
我们假设呼吸道合胞病毒感染可以永久改变免疫系统
通过T细胞产生以下因子对空气变应原的反应
干扰素-α或白介素15对卵子特异性记忆诱导的影响
“旁观者”T淋巴细胞。为了检验这些假设,我们将使用Well
具有RSV感染和卵子致敏特征的小鼠模型,以及
在麻醉状态下,机械地测量乙酰甲胆碱诱导的AHR
采用全身体积描记法测定小鼠通气量。除了定义
呼吸道合胞病毒和卵子诱导的细胞因子和T淋巴细胞亚群在人类免疫缺陷病毒感染中的作用
调解保护或增强AHR、候选疫苗和
将评估免疫治疗方法的能力
降低RSV攻击后卵子致敏小鼠的AHR。
英文摘要
Respiratory syncytial virus (RSV) is the most common viral cause of
severe lower respiratory tract disease in childhood. Severe RSV-induced
disease is associated with childhood asthma, and the incidence of asthma
in industrialized countries is increasing. Therefore, understanding the
molecular and cellular correlates of RSV-and allergen-induced airway
dysfunction is important for devising preventive vaccine and
immunotherapeutic strategies to influence the pathogenesis of childhood
asthma. The objective of this proposal is to define the virologic and
immunologic determinants of airway hyperresponsiveness (AHR) induced by
RSV infection in the setting of allergen sensitization. In particular,
the mechanism of RSV G glycoprotein-induced airway dysfunction will e
defined. In addition, the role of selected cytokines and T cell subsets
on the induction of AHR in ovalbumin (ova)-sensitized, RSV-infected mice
will be defined. Under normal conditions RSV infection induces a Th1-
like pattern of cytokine expression. Our preliminary data supports the
hypothesis that ova-sensitization produces an immunologic environment
that promotes RSV-specific CD4+ Th2 responses to infection which further
potentiate ova-specific allergic airway inflammation and AHR. Further,
we hypothesize that RSV infection can permanently alter the immune
response to aeroallergens through T cell production of factors such as
IFN-alpha or IL-15 that influence memory induction in ova-specific
"bystander" T lymphocytes. To test this hypotheses, we will use well
characterized murine models of RSV infection and ova sensitization, and
measure methacholine-induced AHR in anesthetized, mechanically-
ventilated mice by whole body plethysmography. In addition to defining
the role of RSV- and ova-induced cytokines and T lymphocytes subsets in
mediating protection from or enhancement of AHR, candidate vaccines and
immunotherapeutic approaches will be evaluated for their ability to
reduce AHR in ova-sensitized mice following RSV challenge.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CANARYPOX ALVAC HIV VACCINES IN HIV 1 UNINFECTED ADULT VOLUNTEERS
-
批准号:6305716
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1999
-
负责人:BARNEY S GRAHAM
-
依托单位:
EVALUATE TWO VACCINES IN HEALTHY HIV 1 UNINFECTED ADULTS
-
批准号:6305724
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1999
-
负责人:BARNEY S GRAHAM
-
依托单位:
THERION RECOMBINANT VACCINIA HIV1 IIIB ENV/GAG/POL VACCINE AND MN RGP120/HIV1
-
批准号:6219583
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
LIVE RECOMBINANT CANARY POX ALVAC HIV VCP 300 IN HIV UNINFECTED VOLUNTEERS
-
批准号:6115597
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
ALVAC HIV VCP205 DELIVERED BY ALTERNATE MUCOSAL ROUTES WITH BOOSTING HIV1 SF2
-
批准号:6219580
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
EVALUATE TWO VACCINES IN HEALTHY HIV 1 UNINFECTED ADULTS
-
批准号:6264589
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
UBI KIV LIPOPEPTIDE VACCINE COMPONENT P3C541B IN HIV 1 SERONEGATIVE SUBJECTS
-
批准号:6115594
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
HIV1 GAG/POL DNA VACCINE GIVEN IM BY NEEDLE, SYRINGE AND BIOJECTOR 2000
-
批准号:6115670
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
RECOMBINANT SUBUNIT HIV1 ENVELOPE VACCINES SF 2 RGP120 IN MF59 AND MN RGP120
-
批准号:6219495
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
RECOMBINANT ENVELOPE PROTEIN HIV1 F2 RGP120 WITH MF59
-
批准号:6115603
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
PARTICIPANTS IN HIV 1 PHASE I & II VACCINE TRIALS WHO DEVELOP HIV 1 INFECTIONS
-
批准号:6115635
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
THERION RECOMBINANT VACCINIA HIV1 IIIB ENV/GAG/POL VACCINE AND MN RGP120/HIV1
-
批准号:6115662
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
RECOMBINANT SUBUNIT HIV1 ENVELOPE VACCINES SF 2 RGP120 IN MF59 AND MN RGP120
-
批准号:6115580
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
ALVAC/HIV (VCP205) AND HIV1 SF 2 RGP120 IN HIV 1 UNINFECTED ADULT VOLUNTEERS
-
批准号:6115615
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
ALVAC HIV VCP205 DELIVERED BY ALTERNATE MUCOSAL ROUTES WITH BOOSTING HIV1 SF2
-
批准号:6115659
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
RECOMBINANT ENVELOPE PROTEIN HIV1 F2 RGP120 WITH MF59
-
批准号:6219518
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
P24 VLP PARTICLES IN HIV1 SERONEGATIVE SUBJECTS
-
批准号:6219503
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
LIVE RECOMBINANT CANARYPOX WITH/WITHOUT HIV-1 SF2 RGP120 IN UNINFECTED VOLUNTER
-
批准号:6115668
-
项目类别:
-
资助金额:$3.64万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
ALVAC/HIV (VCP205) AND HIV1 SF 2 RGP120 IN HIV 1 UNINFECTED ADULT VOLUNTEERS
-
批准号:6219530
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
LIVE RECOMBINANT CANARYPOX ALVAC HIV VC205 COMBINED WITH MGCSF
-
批准号:6219605
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:BARNEY S GRAHAM
-
依托单位:
海外基金